Inari Medical is a US-based commercial-stage medical device company founded in 2011. The company's focus on developing products for venous diseases has attracted significant attention from investors, with its Slogan "Extracting Large Clot from Large Vessels" encapsulating its mission. In March 2018, Inari Medical secured a substantial $20.90M Series C investment from notable investors including US Venture Partners, Gilde Healthcare, and Versant Ventures. With a firm footing in the Biotechnology and Health Care industries, the company is poised to make a meaningful impact on patients' lives and the medical device market.
General Information
BounceWatch is an independent company data service, not affiliated with Inari Medical. To contact Inari Medical, visit inarimedical.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Inari Medical
Taxonomy: venous thromboembolism, catheter-based, thrombectomy devices, minimally-invasive, FDA clearance, peripheral vessels, deep vein thrombosis, pulmonary embolism, Inari Medical Inc, medical innovation
Funding Rounds & Investors (4)
View AllInari Medical Alternatives & Competitors
Transforming complex cases into simplified procedures through advanced multi-functional solutions
Innovators in Vascular Technologies
FAQ About Inari Medical
Source: BounceWatch company record for Inari Medical, https://bouncewatch.com/company/inari-medical, updated 5 January 2025. When citing, please name BounceWatch and link this page.